Trial Profile
Open Label, Placebo-Controlled, Single Ascending-Dose, Phase I Safety Study of SMRX 11 (Clot Specific Streptokinase) to Determine Pharmacokinetics and Tolerability in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs SMRX 11 (Primary)
- Indications Thrombosis
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Symmetrix Biotech
- 13 Apr 2016 New trial record